Intellectual property (general education), patent reform (H.R. 9, the Innovation Act; S.632, the STRONG Patents Act) Comprehensive tax reform (no specific bill), orphan drug tax credit (S.1128), R&D tax credit (no specific bill), base erosion (no specific bill), territorial tax system (no specific bill) 340B (no specific bill), Oncology education (no specific bill), adult vaccine policies (no specific bill), adolescent vaccine policies (no specific bill), DISARM (H.R. 4187), ACA Implementation (no specific bill), biosimilars (no specific bill), 21st Century Cures (H.R.6), FDA Regulatory Issues (no specific bill), general pharmaceutical industry issues, Senate HELP Innovation Draft (no bill number) Medicare Part D (general education, no specific bill), changes to low-income subsidy structure in Medicare Part D (general education, no specific bill), sustainable growth rate (H.R. 2, the Medicare Access and CHIP Reauthorization Act), Medicare Part B (general education, no specific bill), Preserving the Integrity of Medicare Act (H.R. 5780)
CPT - Copyright/Patent/Trademark TAX - Taxation/Internal Revenue Code HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
MERCK & CO, INC.
2000 GALLOPING HILL ROAD, KENILWORTH, NJ, 07003, US
ROBERT FILIPPONE ELI JOSEPH ERIN POLAK KATIE OPPENHEIM JENELLE KRISHNAMOORTHY ROBERT FILIPPONE KATIE OPPENHEIM ELI JOSEPH ERIN POLAK ROBERT FILIPPONE ELI JOSEPH KATIE OPPENHEIM ERIN DARLING ERIN POLAK JENELLE KRISHNAMOORTHY ROBERT FILIPPONE ELI JOSEPH KATIE OPPENHEIM ERIN POLAK ERIN DARLING JENELLE KRISHNAMOORTHY